82 related articles for article (PubMed ID: 21552849)
21. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
Caponigro F; Di Gennaro E; Ionna F; Longo F; Aversa C; Pavone E; Maglione MG; Di Marzo M; Muto P; Cavalcanti E; Petrillo A; Sandomenico F; Maiolino P; D'Aniello R; Botti G; De Cecio R; Losito NS; Scala S; Trotta A; Zotti AI; Bruzzese F; Daponte A; Calogero E; Montano M; Pontone M; De Feo G; Perri F; Budillon A
BMC Cancer; 2016 Nov; 16(1):918. PubMed ID: 27884140
[TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacokinetics of intraarterial cisplatin in humans.
Campbell TN; Howell SB; Pfeifle CE; Wung WE; Bookstein J
J Clin Oncol; 1983 Dec; 1(12):755-62. PubMed ID: 6321676
[TBL] [Abstract][Full Text] [Related]
23. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
24. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute.
Bacci G; Ferrari S; Forni C; Mercuri M; Picci P; Bertoni F; Capanna R; Manfrini M; Donati D; Brach Del Prever A; Baldini N
Chir Organi Mov; 1996; 81(4):369-82. PubMed ID: 9147928
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of side effects of a combination chemotherapy of cisplatin and adriamycin in gynecological malignancies: comparison between intravenous and intraarterial administration].
Kawagoe K; Tsunoda H; Iijima S; Yokota H; Shigemitsu S
Gan To Kagaku Ryoho; 1984 Mar; 11(3):452-7. PubMed ID: 6538404
[TBL] [Abstract][Full Text] [Related]
26. Late follow-up of the randomized radiation and concomitant high-dose intra-arterial or intravenous cisplatin (RADPLAT) trial for advanced head and neck cancer.
Heukelom J; Lopez-Yurda M; Balm AJ; Wijers OB; Buter J; Gregor T; Wiggenraad R; de Boer JP; Tan IB; Verheij M; Sonke JJ; Rasch CR
Head Neck; 2016 Apr; 38 Suppl 1():E488-93. PubMed ID: 25728984
[TBL] [Abstract][Full Text] [Related]
27. Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage.
Oldfield EH; Clark WC; Dedrick RL; Egorin MJ; Austin HA; DeVroom HD; Joyce KM; Doppman JL
Cancer Res; 1987 Apr; 47(7):1962-7. PubMed ID: 3815385
[TBL] [Abstract][Full Text] [Related]
28. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
[TBL] [Abstract][Full Text] [Related]
29. [Intra-arterial chemotherapy with cisplatin in advanced urothelial cancer].
Takahashi Y; Uno H; Nagai T; Tamaki M; Nagatani Y; Shinoda I; Takeuchi T; Fujihiro S; Kuriyama M; Kawada Y
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2806-9. PubMed ID: 2782890
[TBL] [Abstract][Full Text] [Related]
30. Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT).
Hoebers FJ; Pluim D; Verheij M; Balm AJ; Bartelink H; Schellens JH; Begg AC
Int J Cancer; 2006 Aug; 119(4):750-6. PubMed ID: 16550603
[TBL] [Abstract][Full Text] [Related]
31. A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive tract.
Foote RL; Kasperbauer JL; Okuno SH; Nichols DA; Olsen KD; Brown PD; Garces YI; Sargent DJ; Strome SE
Cancer; 2005 Feb; 103(3):559-68. PubMed ID: 15597408
[TBL] [Abstract][Full Text] [Related]
32. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.
Kudo M; Ueshima K; Yokosuka O; Ogasawara S; Obi S; Izumi N; Aikata H; Nagano H; Hatano E; Sasaki Y; Hino K; Kumada T; Yamamoto K; Imai Y; Iwadou S; Ogawa C; Okusaka T; Kanai F; Akazawa K; Yoshimura KI; Johnson P; Arai Y;
Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):424-432. PubMed ID: 29631810
[TBL] [Abstract][Full Text] [Related]
33. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
Adachi S; Ogasawara T; Tsubamoto H; Oku H; Hori Y; Tsuji Y; Takemura T; Koyama K
Int J Clin Pharmacol Res; 2001; 21(3-4):105-10. PubMed ID: 12067139
[TBL] [Abstract][Full Text] [Related]
34. Retrograde intra-arterial chemotherapy and daily concurrent proton beam therapy for recurrent oral cavity squamous cell carcinoma: Analysis of therapeutic results in 46 cases.
Hayashi Y; Nakamura T; Mitsudo K; Yamaguchi H; Ono T; Azami Y; Takayama K; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Fuwa N; Tohnai I
Head Neck; 2016 Aug; 38(8):1145-51. PubMed ID: 27018982
[TBL] [Abstract][Full Text] [Related]
35. Superselective arterial infusion chemotherapy for squamous cell carcinomas of the oral cavity: histopathologic effects on metastatic neck lymph nodes.
Ikushima I; Korogi Y; Ishii A; Hirai T; Yamura M; Nishimura R; Baba Y; Yamashita Y; Shinohara M
Eur Arch Otorhinolaryngol; 2007 Mar; 264(3):269-75. PubMed ID: 17061084
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma.
Spring PM; Valentino J; Arnold SM; Sloan D; Kenady D; Kudrimoti M; Haydon RC; Lee C; Given C; Mohiuddin M; Regine WF
Cancer; 2005 Oct; 104(8):1765-71. PubMed ID: 16149090
[TBL] [Abstract][Full Text] [Related]
37. Intra-arterial chemoradiotherapy for head and neck cancer.
Homma A; Onimaru R; Matsuura K; Robbins KT; Fujii M
Jpn J Clin Oncol; 2016 Jan; 46(1):4-12. PubMed ID: 26486825
[TBL] [Abstract][Full Text] [Related]
38. A phase II study of concomitant hyperfractionated radiation therapy and double dose intra-arterial cisplatin for squamous cell carcinoma of the head and neck.
Regine WF; Valentino J; Arnold SM; Sloan D; Kenady D; Strottmann J; Mohiuddin M
Technol Cancer Res Treat; 2002 Apr; 1(2):133-40. PubMed ID: 12622520
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
[TBL] [Abstract][Full Text] [Related]
40. Carotid artery infusion via implantable catheters for squamous cell carcinoma of the tonsils.
Aigner KR; Gailhofer S; Aigner K
World J Surg Oncol; 2018 Jun; 16(1):104. PubMed ID: 29871686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
